摘要
胆道恶性肿瘤的恶性程度高,预后极差,根治性切除是目前唯一可能治愈胆道恶性肿瘤的方法。虽然近几年靶向治疗和免疫治疗发展迅速,但化疗在胆道恶性肿瘤围手术期治疗的基石地位依然无法被取代。围手术期化疗目的包括术前缩小肿瘤体积,使患者获得手术切除的机会和提高根治性切除率,以及术后清除残留肿瘤细胞、预防肿瘤复发等。近年来,不断有学者探索了以化疗为基础的联合治疗模式,以增强围手术期治疗效果,进一步改善患者预后。本文从根治性手术围手术期的化疗方案及临床试验进展的角度,探讨了化疗在胆道恶性肿瘤围手术期的应用价值。
Biliary tract cancer is extremely malignant with a poor prognosis.At the moment,the only curative method available is radical resection.Targeted and immunotherapy are currently advancing rapidly,but chemotherapy still holds a key role in the perioperative treatment of biliary cancer.Perioperative chemotherapy aims to decrease tumor volume prior to surgery so that patients can have their tumors surgically removed or have a higher radical resection rate.It also aims to remove any remaining tumor cells after surgery and prevent the growth of new tumors.Combination treatments based on chemotherapy have been increasingly investigated in recent years to improve perioperative care and patient survival.From the point of view of chemotherapy regimens and clinical trial success in the perioperative phase of radical surgery,the value of chemotherapy in the perioperative period of biliary tract cancer was explored in this paper.
作者
汤朝晖
唐玥
于小鹏
陈家璐
全志伟
Tang Zhaohui;Tang Yue;Yu Xiaopeng;Chen Jialu;Quan Zhiwei(Department of General Surgery,Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Shanghai 200092,China)
出处
《中华外科杂志》
CAS
CSCD
北大核心
2023年第4期277-282,共6页
Chinese Journal of Surgery
基金
国家自然科学基金(81772521)
上海交通大学医学院附属新华医院院级临床研究培育基金(17CSK06)
上海交通大学医学院多中心临床研究(DLY201807)。
关键词
胆道肿瘤
抗肿瘤联合化疗方案
围手术期
辅助治疗
新辅助治疗
转化治疗
Biliary tract neoplasms
Antineoplastic combined chemotherapy protocols
Perioperative period
Adjuvant chemotherapy
Neoadjuvant chemotherapy
Conversion therapy